Association of Life's Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003-2018

被引:0
|
作者
Liu, Xiangliang [1 ]
Chang, Yu [1 ]
Jia, Feng [1 ]
Li, Yuguang [1 ]
Wang, Yao [1 ]
Cui, Jiuwei [1 ]
机构
[1] First Hosp Jilin Univ, 1 Xinmin St, Changchun, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
Life's Essential 8 (LE8); Metabolic dysfunction-associated steatotic liver disease (MASLD); Cardiovascular Health (CVH); Weighted quantile sum regression (WQS) model; Restrictive cubic spline (RCS); NHANES; AMERICAN HEART ASSOCIATIONS; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; HEALTH; PREVALENCE; INDEX; COST; RISK;
D O I
10.1038/s41598-024-67728-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is limited research on the relationship between Life's Essential 8 (LE8) score and metabolic dysfunction-associated steatotic liver disease (MASLD). Our aim is to investigate the relationship between overall lifestyle assessed by LE-8 score and MASLD in a nationally representative sample. We employed the LE8 score to comprehensively evaluate cardiovascular health, the assessment of MASLD primarily utilized the Fatty Liver Index. The weighted logistic regression models, restrictive cubic splines (RCS), subgroup analyses and the weighted quantile sum (WQS) regression were used to evaluate the relationship between the cardiovascular health and MASLD. Logistic regression models revealed that higher LE8 scores were associated with lower odds of having MASLD. The RCS revealed a significant nonlinear dose-response relationship between LE8 scores and MASLD. The WQS regression model indicated that blood glucose contributed the most to the risk of MASLD. The subgroup analysis indicates that there are significant differences in this association across age, educational level, and poverty income ratio. Our study suggests that an inverse correlation between LE8 and the risk of MASLD. Our findings underscore the utility of the LE8 algorithm in MASLD risk assessment and provide support for MASLD prevention through the promotion of healthy lifestyles.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007-2018
    Wang, Yong
    Chen, Shude
    Tian, Chen
    Wang, Qi
    Yang, Zhihua
    Che, Wieqi
    Li, Yike
    Luo, Yang
    [J]. FRONTIERS IN NUTRITION, 2024, 11
  • [2] Association between life's essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults
    Wang, Zheng
    Huang, Bohan
    Ding, Yixuan
    Cao, Feng
    Li, Fei
    Li, Prof Fei
    [J]. ARCHIVES OF PUBLIC HEALTH, 2024, 82 (01)
  • [3] Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study
    Omari, N.
    Simonsen, S.
    Gluud, L. L.
    Martin, H. M.
    Trelle, M. B.
    Jemec, G. B.
    Skov, L.
    Naeslund-Koch, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [4] Association between the composite dietary antioxidant index and metabolic dysfunction-associated steatotic liver disease in adults: a cross-sectional study from NHANES 2017-2020
    Yang, Zheng
    Song, Shupeng
    Li, Lufeng
    Yuan, Zhe
    Li, Yongguo
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    [J]. DIABETES, 2024, 73 (02) : 260 - 279
  • [6] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Kasprzak, Paulina
    Kondracka, Adrianna
    Oniszczuk, Tomasz
    Rusinek, Agata
    Oniszczuk, Anna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [7] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Elshaer, Amani
    Chascsa, David M. H.
    Lizaola-Mayo, Blanca C.
    [J]. LIFE-BASEL, 2024, 14 (07):
  • [8] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
    Chan, Wah-Kheong
    Chuah, Kee-Huat
    Rajaram, Ruveena Bhavani
    Lim, Lee-Ling
    Ratnasingam, Jeyakantha
    Vethakkan, Shireene Ratna
    [J]. JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
  • [9] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
    Sallam, Sandy
    Ahmed, Aijaz
    Gu, Xin
    [J]. DIABETES, 2024, 73
  • [10] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Ramanathan, Raghu
    Patwa, Sohum A.
    Ali, Ahmad Hassan
    Ibdah, Jamal A.
    [J]. CELLS, 2023, 12 (24)